Recombinant Inducible T-Cell Co Stimulator (ICOS) Rattus norvegicus (Rat) Recombinant protein

CD278; AILIM; Inducible T-Cell Costimulator; Activation-Inducible Lymphocyte Immunomediatory Molecule

Add to Cart Distributors
Overview
Properties
  • Source Prokaryotic expression, Host E.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationMembrane
  • Molecular Mass 12.2kDa, Accurate 13kDa(Analysis of differences refer to the manual)
  • Residues & TagsGln39~Glu133 (Accession # Q9R1T7) with N-terminal His Tag
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
  • Traits Freeze-dried powder, Purity > 95%
  • Isoelectric Point6.01
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Recombinant Inducible T-Cell Co Stimulator (ICOS) Packages (Simulation)
  • Recombinant Inducible T-Cell Co Stimulator (ICOS) Packages (Simulation)
  • RPA777Ra01.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Sequence

Usage

pH7.4, containing 0.01% SKL, 5% Trehalose

Storage

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Citations

  • Increased production of soluble inducible costimulator in patients with diffuse cutaneous systemic sclerosisPubmed: 23053221
  • Effect of soluble inducible costimulator level and its polymorphisms on age-related macular degeneration.Pubmed: 24083358
  • Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosisPubmed: 23024058
  • Inducible T‐cell co‐stimulator (ICOS) and ICOS ligand are novel players in the multiple‐myeloma microenvironmentPubmed:34954822
  • Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue DiseasesPubmed:35328257

Recommend products